The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns
With a 1 mg/mL vial, 20 units equals only 0.2 mg
More options for doctor and patient
However, compounded semaglutide might contain different inactive ingredients, such as fillers and binders
The Ozempic Lawsuit alleges that the drug companies failed to provide adequate warnings about the severe gastrointestinal risks associated with their medications, resulting in significant harm and physical suffering for many patients